Skip to main content
OpenTrials

Clinical trial condition

Mastocytosis

Explore clinical trials studying Mastocytosis. Study availability and eligibility vary by location and protocol.

60 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Mastocytosis trial results

Completed

Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis

NCT03401060

Conditions
Bone Diseases, Bone Diseases, Metabolic, Immune System Diseases, +12 more
Locations
  • Jean Minjoz Hospital, Dermatology department Besançon, France
  • Caen Hospital, Clinical haematology department Caen, France
  • Estaing Hospital, Cellular therapy and clinical haematology department Clermont-Ferrand, France
  • Lille CHRU Hospital, Internal medicine and clinical immunology department Lille, France
View Trial Details
Completed

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

NCT02571036

Conditions
Advanced Cancers, Advanced Systemic Mastocytosis, Bronchial Neoplasms, +53 more
Locations
  • Honor Health (GIST, mastocytosis, other solid tumors) Scottsdale, Arizona, United States
  • UCLA Hematology Center (mastocytosis) Los Angeles, California, United States
  • UCLA (glial malignancies only) Los Angeles, California, United States
  • Stanford University Comprehensive Cancer Center (GIST) Palo Alto, California, United States
View all 26 locations
View Trial Details
Completed

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

NCT00897767

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +42 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 214 locations
View Trial Details
Completed

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

NCT02561988

Conditions
Aggressive Systemic Mastocytosis, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM

NCT04695431

Conditions
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Hematologic Diseases, +15 more
Locations
  • Standford Cancer Center Palo Alto, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Medizinische Universitat Wien Vienna, Austria
  • Universitatmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany
View Trial Details

Related conditions